首页> 外文期刊>British Journal of Haematology >BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia
【24h】

BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia

机译:BRAF V600E突变特异性抗体,一种敏感的诊断标记物,可揭示毛细胞白血病中的最小残留病

获取原文
获取原文并翻译 | 示例
           

摘要

The proto-oncogene BRAF, found on chromosome 7q34, encodes a serine/threonine kinase that has a regulatory role in the activation of the mitogen-activated protein kinase (MAPK)/ERK signalling cascade, implicated in cancer induction, maintenance and progression (Ascierto et al, 2012). BRAF is one of the most frequently mutated protein kinase genes in human cancer, with the BRAF V600E mutant (a missense substitution of valine by glutamic acid in a mutational hotspot at ammo acid position 600 of the BRAF protein) commonly present in metastatic melanomas, thyroid carcinoma and colon carcinomas (Cantwell-Dorris et al, 2011).
机译:发现于7q34染色体上的原癌基因BRAF编码一种丝氨酸/苏氨酸激酶,在丝裂原激活的蛋白激酶(MAPK)/ ERK信号级联反应的激活中具有调节作用,与癌症的诱导,维持和进展有关(Ascierto等,2012)。 BRAF是人类癌症中最频繁突变的蛋白激酶基因之一,其BRAF V600E突变体(在BRAF蛋白的氨基酸位置600的突变热点中,谷氨酸对缬氨酸的错义替代)通常存在于转移性黑色素瘤(甲状腺)中癌和结肠癌(Cantwell-Dorris等,2011)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号